发明名称 Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases
摘要 The present invention relates to novel fused heterocyclic or carbocyclic compounds of formula I; wherein the variables are as defined in the claims and the description. The invention further relates to pharmaceutical compositions comprising these compounds, and to their use for the treatment of vasopressin-related disorders.
申请公布号 US9617226(B2) 申请公布日期 2017.04.11
申请号 US201514845727 申请日期 2015.09.04
申请人 AbbVie Deutschland GmbH & Co. KG 发明人 Braje Wilfried;Froggett Jayne;Geneste Hervé;Hornberger Wilfried;Jantos Katja;Kling Andreas;van Gaalen Marcel
分类号 C07D239/91;C07D401/12;C07D403/12;C07D455/02;C07D491/107 主分类号 C07D239/91
代理机构 Neal Gerber & Eisenberg LLP 代理人 Neal Gerber & Eisenberg LLP
主权项 1. A compound of the formula (I) wherein X1, X2, X3, X4 and X5, independently of each other, are N or CH; R1 is C1-C4-alkyl which carries a group —C(═O)R4 or fluorinated C1-C4-alkyl which carries a group —C(═O)R4; R2 is phenyl or a 5- or 6-membered heteroaromatic ring with 1, 2 or 3 heteroatoms selected from the group consisting of O, S and N as ring members, where phenyl or the 5- or 6-membered heteroaromatic ring may carry 1, 2 or 3 substituents R5; R3 is a 3-, 4-, 5- or 6-membered saturated or partially unsaturated carbocyclic ring which carries one substituent R6 and which may additionally carry 1 or 2 substituents R7; R4 is OR8 or —NR9R10; each R5 is independently halogen, cyano, nitro, hydroxyl, C1-C6-alkyl, fluorinated C1-C6-alkyl, C2-C6-alkenyl, fluorinated C2-C6-alkenyl, C2-C6-alkynyl, fluorinated C2-C6-alkynyl, C3-C8-cycloalkyl, fluorinated C3-C8-cycloalkyl, where the 8 last-mentioned aliphatic and cycloaliphatic radicals may carry one or more radicals R15; C3-C8-cycloalkoxy, fluorinated C3-C8-cycloalkoxy, C1-C6-alkoxy, fluorinated C1-C6-alkoxy, C1-C6-alkylthio, fluorinated C1-C6-alkylthio, C1-C6-alkylsulfinyl, fluorinated C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, fluorinated C1-C6-alkylsulfonyl, amino, C1-C6-alkylamino, di-(C1-C6-alkyl)-amino, C1-C6-alkylcarbonyl, fluorinated C1-C6-alkylcarbonyl, carboxyl, C1-C6-alkoxycarbonyl, fluorinated C1-C6-alkoxycarbonyl, C1-C6-alkylcarbonyloxy, fluorinated C1-C6-alkylcarbonyloxy, aminocarbonyl, C1-C6-alkylaminocarbonyl, di-(C1-C6-alkyl)-aminocarbonyl, phenyl, phenyl-C1-C2-alkyl, or a 3-, 4-, 5-, 6-, 7- or 8-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring containing 1, 2 or 3 heteroatoms or heteroatom groups selected from the group consisting of: O, S, N, NO, SO and SO2 as ring members, where phenyl, phenyl-C1-C2-alkyl and the heterocyclic ring may carry one or more radicals R13; or two radicals R5, bound on adjacent ring atoms, form together with the ring atoms to which they are bound a saturated or unsaturated 3-, 4-, 5-, 6-, 7-, 8- or 9-membered ring, wherein the ring may contain 1 or 2 heteroatoms or heteroatom groups selected from the group consisting of O, S, N, NO, SO and SO2 and/or 1 or 2 C═O groups as ring members, and wherein the ring may be substituted by one or more radicals R13; R6 is C1-C4-alkyl which carries a radical —NR11R12 or fluorinated C1-C4-alkyl, which carries a radical —NR11R12; each R7 is independently halogen, cyano, hydroxyl, C1-C4-alkyl, fluorinated C1-C4-alkyl, C1-C4-alkoxy, or fluorinated C1-C4-alkoxy, or two radicals R7 bound on the same carbon ring atom form together a group ═O (oxo); R8 is hydrogen, C1-C6-alkyl, fluorinated C1-C6-alkyl, C2-C6-alkenyl, fluorinated C2-C6-alkenyl, C2-C6-alkynyl, fluorinated C2-C6-alkynyl, C3-C8-cycloalkyl, fluorinated C3-C8-cycloalkyl, where the 8 last-mentioned aliphatic and cycloaliphatic radicals may carry one or more radicals R15; phenyl, phenyl-C1-C2-alkyl, or a 3-, 4-, 5-, 6-, 7- or 8-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring containing 1, 2 or 3 heteroatoms or heteroatom groups selected from the group consisting of: O, S, N, NO, SO and SO2 as ring members, where phenyl, phenyl-C1-C2-alkyl and the heterocyclic ring may carry one or more radicals R13; R9 and R10, independently of each other, are hydrogen, C1-C6-alkyl, fluorinated C1-C6-alkyl, C2-C6-alkenyl, fluorinated C2-C6-alkenyl, C2-C6-alkynyl, fluorinated C2-C6-alkynyl, C3-C8-cycloalkyl, fluorinated C3-C8-cycloalkyl, where the 8 last-mentioned aliphatic and cycloaliphatic radicals may carry one or more radicals R15; C1-C6-alkoxy, fluorinated C1-C6-alkoxy, phenyl, phenyl-C1-C2-alkyl, or a 3-, 4-, 5-, 6-, 7- or 8-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring containing 1, 2 or 3 heteroatoms or heteroatom groups selected from the group consisting of: O, S, N, NO, SO and SO2 as ring members, where phenyl, phenyl-C1-C2-alkyl and the heterocyclic ring may carry one or more radicals R13; or R9 and R10, together with the nitrogen atom they are bound to, form a 3-, 4-, 5-, 6-, 7- or 8-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring, where the heterocyclic ring may additionally contain 1 or 2 heteroatoms or heteroatom groups selected from the group consisting of: O, S, N, NO, SO, SO2 and C═O as ring members, and where the heterocyclic ring may carry 1, 2, 3 or 4 radicals R13; R11 and R12, independently of each other, are hydrogen, C1-C6-alkyl, fluorinated C1-C6-alkyl, C2-C6-alkenyl, fluorinated C2-C6-alkenyl, C2-C6-alkynyl, fluorinated C2-C6-alkynyl, C3-C8-cycloalkyl, fluorinated C3-C8-cycloalkyl, where the 8 last-mentioned aliphatic and cycloaliphatic radicals may carry one or more radicals R15; C1-C6-alkoxy, fluorinated C1-C6-alkoxy, phenyl, phenyl-C1-C2-alkyl, or a 3-, 4-, 5-, 6-, 7- or 8-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring containing 1, 2 or 3 heteroatoms or heteroatom groups selected from the group consisting of: O, S, N, NO, SO and SO2 as ring members, where phenyl, phenyl-C1-C2-alkyl and the heterocyclic ring may carry one or more radicals R13; or R11 and R12, together with the nitrogen atom they are bound to, form a 3-, 4-, 5-, 6-, 7- or 8-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring, where the heterocyclic ring may additionally contain 1 or 2 heteroatoms or heteroatom groups selected from the group consisting of: O, S, N, NO, SO, SO2 and C═O as ring members, and where the heterocyclic ring may carry 1, 2, 3 or 4 radicals R13; each R13 is independently halogen, cyano, hydroxyl, C1-C6-alkyl, fluorinated C1-C6-alkyl, C2-C6-alkenyl, fluorinated C2-C6-alkenyl, C2-C6-alkynyl, fluorinated C2-C6-alkynyl, C3-C8-cycloalkyl, fluorinated C3-C8-cycloalkyl, C3-C8-cycloalkyl-C1-C4-alkyl, C1-C6-alkoxy, fluorinated C1-C6-alkoxy, C1-C6-alkylthio, fluorinated C1-C6-alkylthio, C1-C6-alkylsulfinyl, fluorinated C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, fluorinated C1-C6-alkylsulfonyl, amino, C1-C6-alkylamino, di-(C1-C6-alkyl)-amino, C1-C6-alkylcarbonyl, fluorinated C1-C6-alkylcarbonyl, carboxyl, C1-C6-alkoxycarbonyl, fluorinated C1-C6-alkoxycarbonyl, C1-C6-alkylcarbonyloxy, fluorinated C1-C6-alkylcarbonyloxy, aminocarbonyl, C1-C6-alkylaminocarbonyl, di-(C1-C6-alkyl)-aminocarbonyl, phenyl, or phenyl-C1-C2-alkyl; or two radicals R13 bound to the same carbon ring atom together a group ═O or ═S; or two radicals R13 bound to the same carbon ring atom may form together with this carbon ring atom a 3-, 4-, 5-, 6-, 7- or 8-membered saturated, partially unsaturated or maximally unsaturated ring, where the ring may contain 1, 2, 3 or 4 heteroatoms or heteroatom-containing groups selected from the group consisting of O, S, N, NO, SO, SO2 and C═O as ring members, and where the ring may be substituted with one or more substituents R14; ortwo non-geminal radicals R13 form together a group —(CH2)k—, where k is 1, 2, 3 or 4, where 1 or 2 hydrogen atoms in this group may be replaced by a methyl group; ortwo vicinal radicals R13 form together a group —CH═CH—CH═CH—; each R14 is independently halogen, cyano, hydroxyl, C1-C4-alkyl, fluorinated C1-C4-alkyl, C1-C4-alkoxy, or fluorinated C1-C4-alkoxy; and each R15 is independently cyano, hydroxyl, nitro, C3-C8-cycloalkyl, fluorinated C3-C8-cycloalkyl, C1-C6-alkoxy, fluorinated C1-C6-alkoxy, C1-C6-alkylthio, fluorinated C1-C6-alkylthio, C1-C6-alkylsulfinyl, fluorinated C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, fluorinated C1-C6-alkylsulfonyl, amino, C1-C6-alkylamino, di-(C1-C6-alkyl)-amino, C1-C6-alkylcarbonyl, fluorinated C1-C6-alkylcarbonyl, carboxyl, C1-C6-alkoxycarbonyl, fluorinated C1-C6-alkoxycarbonyl, C1-C6-alkylcarbonyloxy, fluorinated C1-C6-alkylcarbonyloxy, aminocarbonyl, C1-C6-alkylaminocarbonyl, di-(C1-C6-alkyl)-aminocarbonyl, phenyl, or a 3-, 4-, 5-, 6-, 7- or 8-membered saturated, partially unsaturated or maximally unsaturated heterocyclic ring containing 1, 2 or 3 heteroatoms or heteroatom groups selected from the group consisting of O, S, N, NO, SO and SO2 as ring members, where phenyl, phenyl-C1-C2-alkyl and the heterocyclic ring may carry one or more radicals R13; and R15 as a substituent on a cycloaliphatic ring is additionally C1-C6-alkyl, fluorinated C1-C6-alkyl, C2-C6-alkenyl, fluorinated C2-C6-alkenyl, C2-C6-alkynyl, fluorinated C2-C6-alkynyl, or phenyl-C1-C2-alkyl, where the phenyl moiety in phenyl-C1-C2-alkyl may carry one or more radicals R13; or an N-oxide, stereoisomer, or a pharmaceutically acceptable salt thereof, or the compound of the formula I, wherein at least one of the atoms has been replaced by its stable, non-radioactive isotope.
地址 Wiesbaden GB
您可能感兴趣的专利